TROVAGENE ONCOLOGY Trademark
Trademark Overview
On Monday, September 24, 2018, a trademark application was filed for TROVAGENE ONCOLOGY with the United States Patent and Trademark Office. The USPTO has given the TROVAGENE ONCOLOGY trademark a serial number of 88129656. The federal status of this trademark filing is REGISTERED as of Tuesday, June 11, 2019. This trademark is owned by Trovagene, Inc.. The TROVAGENE ONCOLOGY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Pharmaceutical products development; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of cancer; Medical and scientific research in the field of cancer treatment and diagnosis; Pharmaceutical research and development
General Information
| Serial Number | 88129656 |
| Word Mark | TROVAGENE ONCOLOGY |
| Filing Date | Monday, September 24, 2018 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, June 11, 2019 |
| Registration Number | 5777693 |
| Registration Date | Tuesday, June 11, 2019 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, January 15, 2019 |
Trademark Statements
| Description of Mark | The mark consists of the word "TROVAGENE" above the word "ONCOLOGY" and to the right of three hexagon designs. |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| NOT AVAILABLE | "ONCOLOGY" |
| Goods and Services | Pharmaceutical products development; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of cancer; Medical and scientific research in the field of cancer treatment and diagnosis; Pharmaceutical research and development |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, October 1, 2018 |
| Primary Code | 042 |
| First Use Anywhere Date | Tuesday, July 31, 2018 |
| First Use In Commerce Date | Tuesday, July 31, 2018 |
Trademark Owner History
| Party Name | Trovagene, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121 |
| Party Name | Trovagene, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121 |
| Party Name | Trovagene, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121 |
Trademark Events
| Event Date | Event Description |
| Wednesday, December 26, 2018 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, September 27, 2018 | NEW APPLICATION ENTERED |
| Monday, October 1, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, October 2, 2018 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Friday, December 7, 2018 | ASSIGNED TO EXAMINER |
| Friday, December 7, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, January 15, 2019 | PUBLISHED FOR OPPOSITION |
| Tuesday, January 15, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 12, 2019 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, March 20, 2019 | USE AMENDMENT FILED |
| Saturday, April 6, 2019 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Saturday, April 6, 2019 | STATEMENT OF USE PROCESSING COMPLETE |
| Monday, May 6, 2019 | ASSIGNED TO EXAMINER |
| Monday, May 6, 2019 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Tuesday, May 7, 2019 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Tuesday, June 11, 2019 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, June 11, 2024 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Wednesday, March 20, 2019 | TEAS STATEMENT OF USE RECEIVED |
